Peripheral sensory neurons switch to a regenerative state after nerve injury to enable axon regeneration and functional recovery. Whether satellite glial cells (SGC), which completely surround the neuronal soma, contribute to the regenerative responses remains unexplored. Here we defined the transcriptional profile of SGC and identified Fabp7/BLBP as a novel marker of SGC. We report that nerve injury changes gene expression in SGC, which is mostly related to lipid metabolism, specifically fatty acid synthesis and PPARa signaling. Conditional deletion of Fatty acid synthase (Fasn), the committed enzyme in de novo fatty acid synthesis in SGC impairs axon regeneration. Treatment with the PPARa agonist fenofibrate rescues axon regeneration in mice lacking Fasn in SGC. This results indicates that PPARa functions downstream of fatty acid synthesis in SGC to promote axon regeneration. These results identify fatty acid synthesis in SGC as a fundamental novel mechanism mediating axon regeneration in adult peripheral nerves.
INTRODUCTION
Unlike neurons in the central nervous system, peripheral sensory neurons with cell soma in dorsal root ganglia (DRG) switch to a regenerative state after nerve injury to enable axon regeneration and functional recovery. Decades of research have focused on the signaling pathways elicited by injury in sensory neurons (He and Jin, 2016; Mahar and Cavalli, 2018) and
in Schwann cells that insulate axons (Chen et al., 2007b; Jessen and Mirsky, 2016) as central mechanisms regulating nerve repair. However, virtually nothing is known about the contribution of the glial cells that envelop the neuronal soma, known as satellite glial cells (SGC), to the nerve repair process.
In adult animals, multiple SGC form an envelope that completely enwraps each sensory neuron (Hanani, 2005; Pannese, 1981 Pannese, , 2010 . The number of SGC surrounding sensory neurons increases with increasing soma size in mammals (Ledda et al., 2004; Pannese, 1964) . The neuron and its surrounding SGC thus form a distinct morphological and functional unit. Structural neuron-glia units ,similar to these, do not exist in the central nervous system. SGC have been identified mostly based on their morphology and location. Several SGC markers have been characterized, including the inwardly rectifying potassium channel (Kir4.1) (Vit et al., 2008) , cadherin 19 (CDH19) (George et al., 2018) , the calcium activated potassium channel (SK3) (Donegan et al., 2013; Vit et al., 2006) and glutamine synthetase (GS) (Hanani, 2005; Miller et al., 2002) . SGC also share several properties with astrocytes, and express glial fibrillary acidic protein (GFAP) (Hanani, 2005; Stephenson and Byers, 1995) .
SGC have been studied in the context of pain responses and are known to modulate pain thresholds (Hanani, 2015; Huang et al., 2010; Jasmin et al., 2010; Kim et al., 2016b; Warwick and Hanani, 2013) . It is known that SGC are altered structurally and functionally under pathological conditions, such as inflammation, chemotherapy-induced neuropathic pain and nerve injuries (Cherkas et al., 2004; Hanani, 2005; Hanani et al., 2002; Warwick and Hanani, 2013) . Nerve lesions also induce an increase in GFAP expression (Christie et al., 2015; Fenzi et al., 2001; Warwick and Hanani, 2013; Xie et al., 2009; Xu et al., 2008; Zhang et al., 2009) . Increase in p75 and pERK expression has also been observed in SGC after nerve lesions (Obata et al., 2004; Zhou et al., 1996) . An increase in SGC ongoing cell division following nerve injury has also been suggested (Christie et al., 2015; Krishnan et al., 2018) . These studies show that communication between neuron and SGC is critical for neuronal excitability and nociception and that SGC can sense and respond to a distant nerve injury (Huang et al., 2013; Kung et al., 2013) , but whether SGC play a role in regenerative responses has not yet been established.
Using single cell RNA-seq, we reveal that nerve injury alters the gene expression profile in SGC, which is mostly related to lipid metabolism, including fatty acid synthesis. Conditional deletion of Fatty acid synthase (Fasn), the committed enzyme in de novo fatty acid synthesis, specifically in SGC, impairs axon regeneration in peripheral nerves. Treatment with fenofibrate, a PPARa agonist, rescues the impaired axon regeneration observed in mice lacking Fasn in SGC, suggesting that PPARa functions downstream of fatty acid synthesis in SGC to promote axon regeneration. These results unravel lipid synthesis in SGC as a fundamental novel mechanism mediating axon regeneration in adult peripheral nerves.
RESULTS

Single-cell transcriptional profiling identified multiple cell types in naïve and injured DRG
To define the biology of SGC and to understand the role of SGC in nerve injury responses, we performed single cell RNA-seq (scRNA-seq) of mouse L4,L5 DRG in naïve and injured conditions (3 days post sciatic nerve crush injury), using the Chromium Single Cell Gene Expression Solution (10x Genomics) ( Figure 1A ). Graph-based clustering, using Partek flow analysis package, identified 13 distinct cell clusters in the control and injury samples ( Figure 1B ).
Unique cell clusters were not altered by nerve injury ( Figure 1C ). The total of sequenced cells was 6,541 in 2 biological replicates, with an average of 45,000 reads per cell, 1,500 genes per cell and a total of 17,879 genes detected. To identify cluster-specific genes, we calculated the expression difference of each gene between that cluster and the average in the rest of the clusters (ANOVA fold change threshold >1.5), illustrated by a heatmap of the top 5 differentially expressed genes per cluster relative to all other clusters ( Figure 1D and Table 1 ). Examination of the clusterspecific marker genes revealed major cellular subtypes including neurons (Isl1), SGC (KCNJ10/Kir4), Schwann cells (Periaxin, MPZ), endothelial cells (Pecam1/CD31), macrophages (Alf1/Iba-1, CD68), mesenchymal (CD34) connective tissue (Col1A1), T-cells (CD3G) and
Vasculature associated smooth muscle cells (DES). Overlaid cells in t-SNE plots with well characterized marker genes show the relative levels of expression as a color gradient ( Figure   1E ,F and S1A). We anticipated obtaining a larger representation of neurons in our dataset, but their large cell diameter (up to 50 micron for proprioceptors), is likely limiting them from passing through the microfluidic pipes in the Chromium 10X device.
SGC are molecularly distinct from Schwann cells in DRG
The scRNAseq results indicate that SGC represent the largest glial subtype (35%) in the DRG and are molecularly distinct from Schwann cells. The SGC cluster identity was confirmed by the expression of known SGC markers such Kir4.1 (Vit et al., 2008) and CDH19 (George et al., 2018) ( Figure 1E ). While Schwann cells and SGC share the expression of known Schwann cell markers, such as MPZ, MBP and PLP1 ( Figure 1F and S1B), our analysis also revealed Schwann cell specific marker genes such as Myelin Associated Glycoprotein (MAG), Periaxin (PRX) and Non-Compact Myelin Associated Protein (NCMAP) genes that are not expressed in SGC ( Figure 1G and S1B). We next compared the top expressed genes in SGC (605 genes) and
Schwann cells (572 genes), which revealed that SGC share only 2% of genes with Schwann cells in the DRG ( Figure S1C and Table 2 ). SGC also share several properties with astrocytes, including expression of Kir4.1 and glial fibrillary acidic protein (GFAP) (Hanani, 2005; Stephenson and Byers, 1995; Vit et al., 2008) . We thus examined the transcriptional similarity between astrocytes and SGC by comparing the top expressed genes in each cell type, using our scRNAseq data for SGC and a previously published transcriptional analysis of astrocytes (500 genes) (Zhang et al., 2014) . We found that SGC share about 10% of genes with astrocytes, among them Fabp7, Gfap, Ppara and Aldoc ( Figure S1D , Table 2 ). Our single cell RNAseq analysis using freshly dissociated tissue thus unravel a unique transcriptional profile of SGC in DRG and reveals that Schwann cells and SGC are transcriptionally distinct in the DRG.
Fatty acid binding protein7 is a specific marker for adult mouse SGC.
The scRNAseq data revealed that one of the top differentially expressed genes in the SGC cluster is Fatty Acid Binding Protein 7 (Fabp7, also known as BLBP and BFABP) (Table 1, Figure   S1C ). Fabp7 is a nervous system specific member of the hydrophobic ligand binding protein family involved in uptake and transport of fatty acid (Furuhashi and Hotamisligil, 2008) . Fabp7 is involved in signal transduction and gene transcription in the developing mammalian CNS (Feng et al., 1994) , but its precise function remains quite elusive. In the peripheral nervous system, Fabp7 is expressed during embryonic development and distinguishes glia from neural crest cells and neurons during the early stages of development (Britsch et al., 2001; Kastriti and Adameyko, 2017; Weider et al., 2015) . These observations prompted us to test if Fabp7 can be used as a novel marker of SGC in adult mouse DRG. We found that Fabp7 labels SGC surrounding sensory neuron soma (Figure 2A ). The specificity of the Fabp7 antibody was verified using DRG and sciatic nerve from the Fabp7KO mouse (Owada et al., 2006) 
signal surrounding neurons is lost, but SGC are present and stained with glutamine synthetase (GS) (Hanani, 2005; Miller et al., 2002) . Importantly, Fabp7 does not label Schwann cells surrounding axons in the DRG (Figure 2A , asterisks), or in the sciatic nerve ( Figure S2C ) consistent with previous reports (Kurtz et al., 1994; Miller et al., 2003) and our single cell analysis ( Figure 2B ). We next tested if the BLBPcre-ER mouse line (Maruoka et al., 2011) can be used to label and manipulate SGC specifically. We crossed BLBPCre-ER to the Rosa26-fs-TRAP and observed that following 10 days tamoxifen treatment, BLBPcre-ER mice drove expression of the GFP reporter in SGC ( Figure 2C , upper panel). To further ensure that the BLBPcre-ER is specifically expressed in SGC in the DRG and does not drive expression in Schwann cells in the nerve, we crossed BLBPcre-ER to the Sun1-sfGFP-myc (INTACT mice: R26-CAG-LSL-Sun1-sfGFP-myc) (Mo et al., 2015) , which allows GFP expression in the nuclear membrane. We found GFP positive nuclei around the neurons in DRG sections ( Figure 2C , lower panel) and no nuclear GFP expression axons in naïve sciatic nerves ( Figure 2D ). Since a role for Fabp7 in regulating Schwann cell-axon interactions has been proposed (Miller et al., 2003) , with Fabp7 expressed 2 to 3 weeks after nerve injury when Schwann cell process formation is exuberant, we also examined nuclear GFP expression in injured nerves. We found that 3 days post injury, 4% and 7% of the nuclei expressed the GFP reporter proximal and distal to the injury site, respectively ( Figure 2D ,E). This is consistent with a prior report showing that BLBP is not present 4 to 7 days post injury, but is expressed in some cells starting 14 days post injury (Miller et al., 2003) . Since typically, 50% of nuclei express c-jun, a marker for Schwann cells response to injury, two days after injury in the nerve (Blom et al., 2014) , the GFP positive nuclei we observed, may represent a very small subset of Schwann cells responding to injury. To further confirm the specificity of the BLBPCreER reporter following nerve injury, we re-analyzed a single cell data set from injured nerve (9 days post injury) (Carr et al., 2019) . We found that less than 5% of cells in the Schwann cell cluster expressed Fabp7 ( Figure S2D ). A comparative analysis of the transcriptome of injured nerve (3 days post injury) also demonstrated very low counts of Fabp7 in proximal and distal nerve segments (Shin et al., 2018) . Together, these experiments reveal that Fabp7 represents a novel marker of SGC and that the BLBPcre-ER mouse line can be used to label and manipulate SGC, with only minimal impact on Schwann cells at early time points after nerve injury.
SGC upregulate lipid metabolism in response to nerve injury
To define the transcriptional response of SGC to nerve injury, cells in the SGC cluster were pooled and control and injury conditions were compared to identify differentially expressed genes. 1,255 genes were differentially upregulated in SGC after injury (FDR>0.05, Log2Fold change>2) (Table 3 ) and analyzed for enriched biological pathways using KEGG 2016 (Kyoto Encyclopedia of Genes and Genomes). This analysis revealed enrichment in lipid metabolic pathways, including fatty acid biosynthesis ( Figure 3A ). Pathway analysis of other major cells types in the DRG confirmed fatty acid metabolism as a unique pathway enriched in SGC in response to nerve injury ( Figure S3A -F). Although both SGC and macrophages were suggested to undergo cell cycle after nerve injury (Krishnan et al., 2018) , our pathway analysis indicate that the cell cycle term is enriched in macrophages, but not SGC (Figure 3 and S3A).
One of the genes enriched in SGC is fatty acid synthase (Fasn), the committed enzyme in de novo fatty acid synthesis (Dean and Lodhi, 2018) ( Figure 3B and Table 2 ). Immunostaining of DRG sections confirmed Fasn expression in SGC surrounding sensory neuron soma ( Figure   3C , upper panel). These observations prompted us to investigate the role of Fasn in SGC. We generated an SGC specific Fasn KO mouse (FasncKO) by crossing BLBPcre-ER (Maruoka et al., 2011) mice to mice carrying floxed Fasn alleles (Chakravarthy et al., 2005) . 8 week old BLBPcre-ER ;Fasn f/f (FasncKO) and BLBPcre-ER -;Fasn f/+ mice (control) were fed with tamoxifen for 10 days to conditionally delete Fasn in SGC. This design allows us to ensure that both control and FasncKO groups are treated with tamoxifen and thus differences between groups do not result from the tamoxifen treatment itself. Expression of Fasn in SGC visualized by immunofluorescence was significantly reduced in the FasncKO DRG compared to control littermates ( Figure 3C Figure 3E ). Fasn has been shown to be expressed in Schwann cells (Montani et al., 2018) , and immunostaining for Fasn in the sciatic nerve confirms these results ( Figure 3D ,E). However, Fasn expression was not affected in the nerve of FasncKO mice ( Figure 3D ,E and F) confirming the specificity of the BLBPCre-ER line for SGC.
Deletion of Fasn in SGC does not alter SGC morphology or functional properties.
To determine the impact of Fasn deletion on SGC morphology, we performed transmission electron microscopy (TEM), as previously reported (Pannese, 1964 (Pannese, , 2010 . We observed no abnormalities in the morphology of the SGC surrounding the neuron somas in the FasncKO animals compared to controls ( Figure 4A , SGC were pseudo colored). The SGC sheath is smooth and separated from the sheaths enclosing the adjacent nerve cell bodies by a connective tissue space, as described extensively previously (Pannese, 1964 (Pannese, , 2010 . The SGC coat is also in direct contact with the neuronal membrane, as described (Pannese, 1964 (Pannese, , 2010 . We next evaluated both Remak bundle structure and myelin sheath thickness in the nerve of the FasncKO mice compared to control animals ( Figure 4B -F). Neither the number of axons per Remak bundle nor the myelin thickness and axon diameter was altered in the FasncKO. To confirm that the reduction of Fasn in SGC does not cause neuronal cell death, we immunostained sections of DRG from FasncKO and control mice for the apoptotic marker cleaved caspase 3 before and after injury ( Figure S4A ). Quantification of Caspase 3 intensity revealed no change in cell death in naïve conditions and three days post injury between FasncKO and control ( Figure 4G and S4A). We next examined the expression of Atf3, an established neuronal injury marker (Holland et al., 2019; Mahar and Cavalli, 2018) . Atf3 levels in control and FasncKO animals were very low in the absence of injury ( Figure 4H ), indicating that in naïve condition, Fasn deletion in SGC did not cause a stress response in DRG neurons. Nerve injury increased the mRNA levels of Atf3 in control and FasncKO DRG, but this response was less robust in the FasncKO ( Figure 4H ), Together, these results indicate that loss of Fasn in SGC does not lead to morphological deficits in the DRG and does not elicits a stress response in neurons.
The robust bidirectional communication between neurons and SGC is critical for neuronal excitability and nociception (Huang et al., 2013) and the excitability of sensory neurons is controlled in part by the surrounding SGC (Chen et al., 2015; Kim et al., 2016b; Suadicani et al., 2010; Zhang et al., 2007; Zhang et al., 2005) . To examine whether Fasn deletion in SGC affected functional properties of DRG neurons, we compared intrinsic excitability and firing properties of DRG neurons from FasncKO and control mice. Whole-cell recordings were performed in acutely dissociated co-cultures of DRG neurons and glia. Medium diameter neurons that were associated with at least one glial cell were targeted for recordings ( Figure S4B ). A subset of recorded cells was filled with biocytin via the patch pipette for post hoc verification of neuronal identity. The vast majority of filled cells were identified as IB4-positive nociceptors ( Figure S4C ). We observed that all major features of intrinsic neuronal excitability were unaffected in DRG neurons from FasncKO mice compared to controls, including the resting membrane potential ( Figure 4I ), membrane capacitance ( Figure 4J ), and input resistance ( Figure 4K ). We further examined the spiking properties of DRG neurons and found no detectable changes in action potential threshold ( Figure   4M ), which represents the principle determinant of neuronal excitability, or the neuronal firing frequency ( Figure 4L ,N) in FasncKO mice compared to controls. Therefore, Fasn deletion in SGC does not affect functional properties of DRG neurons.
Deletion of Fasn in SGC impairs axon regeneration.
We observed that Atf3 expression after injury was reduced in FasncKO compared to control ( Figure 4H ), suggesting that absence of Fasn in SGC may impact the neuronal response to injury. To test the consequence of Fasn deletion in SGC on axon regeneration, we used our established in vivo and ex-vivo regeneration assays (Cho and Cavalli, 2012; Cho et al., 2015; Cho et al., 2013) . Two weeks after tamoxifen treatment, we performed a sciatic nerve crush injury in FasncKO and control mice and measured the extent of axon regeneration past the injury site three days later by labeling nerve sections with SCG10, a marker for regenerating axons (Shin et al., 2014) . Loss of Fasn in SGC impaired axon regeneration, demonstrated by reduced axonal length and lower regeneration capacity ( Figure 5A -C). We also tested if loss of Fasn has an effect on the conditioning injury paradigm, in which a prior nerve injury increases the growth capacity of neurons (Smith and Skene, 1997) . Isolated DRG neurons from naïve and injured FasncKO and control mice were cultured for 20h ( Figure 5D ). In naïve animals, typically only few neurons extend short neurites, whereas a prior injury leads to more neurons initiating neurite growth and longer neurites ( Figure 5D -F). In FasncKO mice, naïve neurons presented similar neurite length to control naïve animals with a similar initiation rate. In contrast, a prior injury in FasncKO mice only partially conditioned the neurons for growth. Neurons in injured FasncKO displayed reduced neurite length compared to injured controls, but similar initiation rates ( Figure 5D -F). These results indicate that Fasn in SGC is required for the conditioning effect, and specifically for the elongating phase of axon growth.
Activation of PPARa in SGC contributes to axon regeneration
To understand the mechanism by which Fasn in SGC regulates axon regeneration, we examined the role of peroxisome proliferator-activated receptors (PPARs), which represent a unique set of lipid regulated transcription factors (Varga et al., 2011) . Fasn synthesizes palmitic acid, which is the substrate for the synthesis of more complex fatty acids (Dean and Lodhi, 2018) .
In the liver, Fasn is required for generating the endogenous ligand for PPARa (Chakravarthy et al., 2009) , whereas in adipose tissue, Fasn, is required for generating endogenous ligands for PPARg (Lodhi et al., 2012) . Our scRNAseq analysis revealed that PPARa, but not PPARg, was enriched in the SGC cluster, along with known PPARa target genes PPARGC1a, FADS2 and PEX11A (Rakhshandehroo et al., 2010) (Figure 6A ). These PPARa target genes were also upregulated after injury in the SGC cluster ( Figure 6B and Table 3 ). PPARa regulates the expression of genes involved in lipid and carbohydrate metabolism (Varga et al., 2011) . This is consistent with our GO analysis of upregulated genes after injury that indicated an enrichment of the PPAR signaling pathway and lipid metabolism in SGC after injury ( Figure 3A and S3 ). We further confirmed the enrichment of PPARa target genes in SGC vs. neurons using the RNAseq data set from purified nociceptors in naïve condition and 3 days post injury (Carlin et al., 2019) ( Figure 6B ). These observations indicate that PPARa signaling is enriched in the SGC cluster and suggest that fatty acid synthesis in injured SGC regulate PPAR-dependent transcription.
Whereas biologic PPARa agonists consist of a broad spectrum of ligands (Rakhshandehroo et al., 2010) , synthetic PPARa agonists include clofibrate, fenofibrate, bezafibrate, gemfibrozil, Wy14643 and GW7647. To test the effect of these PPARa agonists on axon regeneration, we modified our spot culture assay, in which embryonic DRG are dissociated and cultured in a spot, allowing axons to extend radially from the spot (Cho and Cavalli, 2012; Cho et al., 2013) . By not including the mitotic inhibitor 5-deoxyfluoruridine (FDU) to eliminate dividing cells, we observed SGC, labeled with Fabp7 in the cell soma area, where they surround neurons by DIV7 ( Figure 6C, S5A ,B) but not in the axon region ( Figure 6C, S5A,B ). The PPARa agonists clofibrate, fenofibrate, Wy14643 and GW7647 were added to the media at 2 concentrations (10µM and 100nM) at DIV6. Axons were cut using a microtome blade at DIV7 and allowed to regenerate for 24h, fixed and stained for SCG10 to visualize axon regeneration (Shin et al., 2014) . Regenerative length was measured from the visible blade mark to the end of the regenerating axon tips ( Figure 6D ,E). Whereas Wy14643 and GW7647 had no effect on axonal regeneration compared to DMSO, clofibrate (100nM) and fenofibrate (100nM, 10µM) increased axon growth after axotomy ( Figure 6E ). However, clofibrate at a higher concentration (10µM) caused cell death and axonal degeneration. To ensure that the increased regeneration effect was mediated by SGC and was not due to PPAR activation in neurons, we tested fenofibrate, clofibrate and GW7647 in spot cultures treated with FDU, in which no Fabp7 positive cells was detected at DIV7 ( Figure S5B ). In these conditions, we observed no increase in axon regeneration ( Figure 6F and S5C). These results indicate that activation of PPARa signaling in SGC promote axon growth, although we cannot fully exclude that other cell types present in the spot culture contribute to this effect.
Activation of PPARa with fenofibrate rescues the impaired axon regeneration in FasncKO mice
In the absence of Fasn in SGC, PPARa may lack its endogenous agonist and PPARa signaling following nerve injury may be compromised. To test this hypothesis, we determined if fenofibrate can rescue the axon regeneration defects that we observed in the FasncKO mice. We chose fenofibrate for these in vivo experiments because it is FDA-approved to treat dyslipidemia (Rosenson, 2008) , is a specific PPARa agonist with minimal activity towards PPARg and can be delivered easily in the diet (Kim et al., 2016a) . Control and FasncKO mice were fed with chow supplemented with fenofibrate, as described (Kim et al., 2016a) for 2 weeks prior to nerve injury.
PPARa as well as PPARa target gene expression were upregulated in the DRG of fenofibrate fed mice compared to mice fed with a normal diet ( Figure 7A ). The impaired axon regeneration in FasncKO mice was rescued by the fenofibrate diet ( Figure 7B-D) . The fenofibrate diet also rescued the impaired axon growth in the conditioning paradigm ( Figure 7E ,F), with no change in initiation rate ( Figure 7G ). These results are consistent with the notion that in response to axon injury, Fasn expression in SGC activates PPARa signaling to promote axon regeneration in adult peripheral nerves.
DISCUSSION
The role of SGC in nerve regeneration has been largely ignored and the biology of SGC is very poorly characterized under normal or pathological conditions. Our unbiased single cell approach characterized the molecular profile of SGC and demonstrated that SGC play a previously unrecognized role in peripheral nerve regeneration, in part via injury induced activation of PPARa signaling.
SGC have been identified mostly based on their morphology and location. Several SGC markers have been characterized, but no useful markers that can be used to purify SGC and understand their biology at the molecular level have been identify so far. Although a previous study reported that SGC are very similar to Schwann cells (George et al., 2018) , this conclusion was drawn from the analysis of cultured and passaged SGC and Schwann cells. Other SGC isolation methods rely on immunoreactivity to SK3 (Jager et al., 2018) or on multiple sucrose gradients and cell plating (George et al., 2018) . Our single cell approach provides the advantage of minimal time between dissociation and analysis and is capturing more accurately the actual transcription status of the cells. Using this method, we demonstrate that SGC represent a unique cell population in the DRG, which share some molecular markers with Schwann cells as well as astrocytes. We also characterized a new marker for adult SGC and a mouse line, BLBP-creER (Maruoka et al., 2011) , that can be used to manipulate SGC specifically in the DRG. Because Fabp7 is expressed in radial glial cells as well as neuronal progenitors and is critical for neurogenesis in the CNS (Feng et al., 1994; Matsumata et al., 2016; Matsumata et al., 2012) , this mouse line needs to be used in an inducible manner in adult mice to avoid targeting other cells during development. It is also important to note that Fabp7 is expressed in astrocytes, where it is important for dendritic growth and neuronal synapse formation (Ebrahimi et al., 2016) as well as for astrocyte proliferation during reactive gliosis (Sharifi et al., 2011) , and thus the BLBP-creER line will also target astrocytes in the central nervous system. SGC are believed to share common features with astrocytes, such as expression of Kir4.1 and functional coupling by gap junctions (Christie et al., 2015; Donegan et al., 2013; Hanani, 2005; Huang et al., 2005) , with SGC surrounding the same neuron connected by gap junctions. The BLBP-creER mouse line thus represents a new tool to study SGC in the peripheral nervous system.
PPARs are ligand-activated nuclear receptors with the unique ability to bind lipid signaling molecules and transduce the appropriate signals derived from the metabolic environment to control gene expression (Varga et al., 2011) . Accordingly, PPARs are key regulators of lipid and carbohydrate metabolism. PPARs can sense components of different lipoproteins and regulate lipid homeostasis based on the need of a specific tissue (Lee et al., 2003) . Three different PPAR subtypes are known; PPARa, PPARb/d and PPARg (Lee et al., 2003) . All share the same molecular mode of activation, forming a heterodimer with the nuclear receptor RXR, followed by binding to specific DNA-response elements in target genes (PPAREs). PPARg is important in neurons for axon regeneration (Lezana et al., 2016) . However PPARg is not expressed in SGC according to our scRNAseq data. Rather, our results indicate that PPARa is enriched in SGC and required for efficient nerve regeneration. Fenofibrate is a specific PPARa agonist, making it unlikely that the rescue effects we observed in FasncKO mice are due to activation of PPARg in neurons. PPARa and PPARa target genes are also highly enriched in SGC, suggesting that fenofibrate act on SGC rather than other resident cells in DRG to enhance axon regeneration.
Furthermore, we show that fenofibrate does not improve axon regeneration in neuronal cultures that do not contain SGC. Fenofibrate is used clinically to treat lipid disorders, but has been unexpectedly been shown in clinical trials to have neuroprotective effects in diabetic retinopathy (Bogdanov et al., 2015; Moreno and Ceru, 2015) and in traumatic brain injury (Chen et al., 2007a) .
Our findings suggest that fenofibrate may be used to activate SGC and enhance axon regeneration in circumstances with poor sensory axon growth, such as after injury to dorsally projecting sensory axons in the spinal cord or peripheral nerve repair. Although fenofibrate treatment did not improve locomotor recovery following spinal contusion injury in mice (Almad et al., 2011) , a slight trend for increased tissue sparing was observed. Whether fenofibrate can improve centrally projecting sensory axon growth will need to be rigorously tested.
Biologic PPARa agonists consist of saturated and unsaturated fatty acids, eicosanoids and glucocorticoids (Lee et al., 2003) . Fasn synthesizes palmitic acid, which is the substrate for the synthesis of more complex fatty acids (Dean and Lodhi, 2018) . Fasn is partially localized in peroxisomes, where ether lipids such as plasmalogens are synthesized (Dean and Lodhi, 2018) .
In the liver, Fasn is required for generating the endogenous ligand for PPARa (Chakravarthy et al., 2009) , whereas in adipose tissue, Fasn is required for generating endogenous ligands for PPARg (Lodhi et al., 2012) . One interpretation of our findings is that in SGC, Fasn is required to generate ligands for PPARa and that following nerve injury, Fasn dependent lipid metabolism and PPARa target genes are upregulated to promote axon regeneration.
How do lipid metabolism and PPARa signaling in SGC contribute to stimulate axon regeneration? Although addressing this question will require further investigation, our data indicate that Fasn expression in SGC is required for the proper expression of at least one regeneration associated gene after injury, Atf3. This finding suggests that SGC contribute to regulate gene expression in neurons. It is also plausible that SGC impact neurons through lipid transfer. Indeed, lipids can be exogenously supplied by lipoproteins secreted from glial cells to stimulate neurite growth. Several studies have suggested a role for ApoE, a PPARa target gene, in lipid delivery for growth and regeneration of axons after nerve injury (Li et al., 2010; Vance et al., 2000; Vance et al., 1994) and ApoE expression is increased in glial cells after nerve injury (LeBlanc and Poduslo, 1990; Snipes et al., 1986) . In agreement with these previous reports, our data indicate that ApoE mRNA levels are elevated in SGC after nerve injury and also following fenofibrate treatment ( Figure 6B and 7A) . In astrocytes, lipid metabolism is critical for synapse development and function in vivo (Barres and Smith, 2001; van Deijk et al., 2017) . It will therefore be interesting to determine if lipid metabolism in SGC play a direct role in axon regeneration through paracrine effects on neurons.
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Material and Methods
Animals and Procedures
All surgical procedures were completed as approved by Washington University in St. Louis School of Medicine Institutional Animal Care and Use Committee's regulations. During surgery, 8-12 week old C57Bl/6 mice or the indicate genotype were anesthetized using 2% inhaled isoflurane. For analgesia, 1mg/kg buprenorphine SR-LAB (ZooPharm) was administered subcutaneously. Sciatic nerve injuries were performed as previously described (Carlin et al., 2019; Cho et al., 2013) . Briefly, the sciatic nerve was exposed and crushed for 10 seconds using a #55 forceps. The wound was closed using wound clips and both injured dorsal root ganglia and sciatic nerve were dissected at the indicated time post-surgery. Contralateral nerve and DRG served as uninjured controls, when needed. Tamoxifen (500mg per kg diet, TD.130858) and
Fenofibrate (0.2%, Sigma Cat# F6020) were administrated as chow pellets (Envigo Tekland).
Mouse strains
Male and female mice were used for all experiments. 8-10 weeks old -12 week old C57Bl/6 were used. Rosa26-ZsGreen (also known as Ai6(RCL-ZsGreen) was obtained from Jackson RRID:IMSR_JAX:007906; (Madisen et al., 2010) . Fabp7KO mouse line was a generous gift from Dr. Owada (Owada et al., 2006) . The Sunf1GFP mice (Gt(ROSA)26Sortm5(CAG-Sun1/sfGFP)Nat) was a generous gift from Dr. Harrison Gabel. mice carrying floxed Fasn alleles were previously generated (Chakravarthy et al., 2005) . The BLBP-cre ER mouse line (Maruoka et al., 2011) was a generous gift from Dr. Toshihiko Hosoya. Partek Flow package.
Single cell RNAseq
Data Deposition
The Fastq files for scRNA sequencing were deposited at the NCBI GEO database under the accession number GSE139103.
Tissue Preparation and Immunohistochemistry
After isolation of either sciatic nerve or DRG, tissue was fixed using 4% paraformaldehyde for 1 hour at room temperature. Tissue was then washed in PBS and cryoprotected using 30% sucrose solution at 4C overnight. Next, the tissue was embedded in O.C.T., frozen, and mounted for cryosectioning. All frozen sections were cut to a width of 12µm for subsequent staining. For immunostaining of DRG and nerve sections, slides were washed 3x in PBS and then blocked for in solution containing 10% goat serum in .2% Triton-PBS for 1 hour. Next, sections were incubated overnight in blocking solution containing primary antibody. The next day, sections were washed 3x with PBS and then incubated in blocking solution containing a secondary antibody for 1 hour at room temperature. Finally, sections were washed 3x with PBS and mounted using ProLong Gold antifade (Thermo Fisher Scientific). Images were acquired at 10x or 20x using a Nikon 
DRG Cultures and Regeneration Assays
For in vitro regeneration assay, dorsal root ganglia were isolated from time pregnant e13.5 CD-1 mice and cultured as previously described (Cho et al., 2013; Oh et al., 2018) . Briefly, after a short centrifugation, dissection media was aspirated and cells were digested in .05% Trypsin-EDTA for 25 minutes in 37 o C. Next, cells were pelleted by centrifuging for 2 minutes at 500 x g, the supernatant was aspirated, and Neurobasal was added. Cells were then triturated 25x and added to the growth medium containing Neurobasal media, B27 Plus, 1ng/ml NGF, Glutamax and Pen/Strep, with or without 5μM 5-deoxyfluoruridine (FDU). Approximately 10,000 cells were added to each well in a 2.5 μl spot. Spotted cells were allowed to adhere for 10 minutes before the addition of the growth medium. Plates were pre-coated with 100ug/ml poly-D-lysine. For regeneration assays, PPARa agonists were added to the culture on DIV6. Cells were then injured using an 8mm microtome blade on DIV7 and fixed 24h later. Cells were washed with PBS and stained for SCG10 as described above.
For adult DRG cultures DRG were dissected from naïve mice. Cells were prepared as described above for single cell protocol and cultured on 100ug/ml poly-D-lysine coated plates and fixed 20h later. Cultures were then used for electrophysiological recording 24h after plating or fixed and stained with the indicated antibody. Images were acquired at 10x using a Nikon TE2000 microscope and image analysis was completed using Nikon Elements.
Image Analysis
For sciatic nerve injury experiments, images were quantified in two ways. First, the injury site was defined as the area with maximal SCG10 intensity. A vertical line was drawn across this region and the longest 10 axons were measured from that site and the average length reported (Carlin et al., 2019) . Next, SCG10 intensity was quantified at 1, 2, and 3mm from the injury site as previously described (Cho et al., 2015; Cho et al., 2013) . The intensity was normalized to the injury site and the percent intensity was reported. For both quantifications, five sections per biological replicate were averaged.
For embryonic dorsal root ganglia experiments, regenerative length was measured from the visible blade mark to the end of the regenerating axons. Each technical replicate was measured 4-6 times and three technical replicates were measured per biological replicate.
To determine the cleaved caspase staining area, a binary was generated to fit the positive signal, and positive staining area was measured. That area was internally normalized to Dapi positive staining area.
RNA Isolation and Quantitative PCR
DRG and nerves were lysed and total RNA was extracted using Trizol reagent (Thermo Fisher, Cat# 15596026).). Next, RNA concentration was determined using a NanoDrop 2000 (Thermo Fisher Scientific). First strand synthesis was then performed using the High Capacity cDNA Reverse Transcription kit (Applied Biosystems). Quantitative PCR was performed using PowerUp SYBR Green master mix (Thermo Fisher, Cat# a25742) using 5ng of cDNA per reaction.
Plates were run on a QuantStudio 6 Flex and analyzed in Microsoft Excel. The average Ct value from three technical replicates was averaged normalized to the internal control Rpl13a. All primer sequences were obtained from PrimerBank (Spandidos et al., 2010) 
Electrophoresis and western blot
DRG and sciatic nerve samples were lysed in 5× SDS loading buffer, heated at 95 °C for 5 min and were run in on 8-16% NuPAGE SDS-PAGE gradient gel (Life Technologies) in MOPS SDS Running Buffer (Life Technologies) and transferred to 0.45 μm nitrocellulose membranes (Amersham). Next, these membranes were blocked in blocking buffer (3% BSA in 0.1% Tween-20 at pH 7.6 for 1 h, and incubated at 4 °C overnight in blocking buffer with primary antibodies.
Membranes were then washed in TBST 3 times, incubated with horseradish peroxidase (HRP)conjugated anti-rabbit or anti-mouse IgG (Invitrogen) for 1 h at room temperature, washed in TBST three times, and developed with SuperSignal West Dura Chemiluminescent Substrate (Thermo Scientific). The membranes were imaged using ChemiDoc System (Bio Rad) and analyzed with ImageLab software. For quantification, Fasn intensity was normalized to loading control Gapdh (Santa Cruz, catalog# sc25778)
Whole-cell electrophysiology
Whole-cell patch-clamp recordings in a current-clamp mode were performed using a Multiclamp 700B amplifier (Molecular Devices) from acutely isolated DRG neurons visually identified with infrared video microscopy and differential interference contrast optics (Olympus BX51WI). Current-clamp recordings were made with pipette capacitance compensation and bridge-balance compensation. Recordings were conducted at near-physiological temperature (33-34°C). The recording electrodes were filled with the following (in mM): 130 K-gluconate, 10 KCl, 0.1 EGTA, 2 MgCl2, 2 ATPNa2, 0.4 GTPNa, and 10 HEPES, pH 7.3. The extracellular solution contained (in mM): 145 NaCl, 3 KCl, 10 HEPES, 2.5 CaCl2, 1.2 MgCl2, and 7 glucose, pH 7.4 (saturated with 95% O2 and 5% CO2). For determination of action potential (AP) threshold, APs were evoked by a ramp current injection (0.1 pA/ms) (Deng and Klyachko, 2016; Yamada-Hanff and Bean, 2013) with a hyperpolarizing onset to ensure maximal Na + channel availability before the first AP. The AP thresholds were determined only from the first APs of ramp-evoked AP trains.
AP threshold (i.e., threshold voltage) was defined as the voltage at the voltage trace turning point, corresponding to the first peak of 3rd order derivative of AP trace (Deng and Klyachko, 2016; Lu et al., 2012) . Data were averaged over 5-8 trials for each cell. Resting membrane potential (RMP) was measured immediately after whole-cell formation. Cell capacitance was determined by the amplifier's auto whole-cell compensation function with slight manual adjustment to optimize the measurement if needed. Under current-clamp mode, a negative current (−50 pA for 500 ms) was injected every 5 s to assess the input resistance.
TEM
Mice were perfused with 2.5% glutaraldehyde with 4% paraformaldehyde in 0.1M Cacodylate buffer, followed by post fix. A secondary fix was done with 1% osmium tetroxide. For Transmission electron microscopy (TEM), tissue was dehydrated with ethanol and embedded with spurr's resin. Thin sections (70 nm) were mounted on mesh grids and stained with 8% uranyl acetate followed by Sato's lead stain. Sections were imaged on a Jeol (JEM-1400) electron microscope and acquired with an AMT V601 digital camera. (Washington University Center for Cellular Imaging).
Quantification and statistical analysis
Quantifications were performed by a blinded experimenter to genotype and treatment. Fiji 
